NCI NCTN-Network Lead Academic Participating Site at UPMC Hillman Cancer Center

项目概要/摘要 国家临床试验网络（NCTN）领导学术参与中心在UPMC希尔曼的目标 癌症中心，是为了提高我们的参与水平，在概念化，发展，激活， NRG Oncology、ECOG-ACRIN和ECOG-ACRIN的晚期临床试验的性能和报告 肿瘤学临床试验联盟网络组。这将通过提高质量来实现 我们的科学和行政领导;增加应计NCTN试验，特别努力 针对少数民族、农村和其他特殊人群;改进我们的程序， 试验，特别是针对罕见癌症和基因型定义的亚群的试验;以及 指导初级研究人员如何进行2期和3期NCTN试验，以及行政管理， 科学和人际交往能力，需要推进到NCTN内的领导地位， 美国国家癌症研究所.

Project Summary/Abstract The goal of the National Clinical Trials Network (NCTN) Lead Academic Participating Site at UPMC Hillman Cancer Center, is to increase our level of participation in conceptualization, development, activation, performance, and reporting of the late-phase clinical trials of the NRG Oncology, ECOG-ACRIN, and Alliance for Clinical Trials in Oncology Network Groups. This will be accomplished by enhancing the quality of our scientific and administrative leadership; increasing accruals to NCTN trials, with special efforts directed at minority, rural and other special populations; improving our processes for rapid activation of new trials, with special efforts directed at trials for rare cancers and genotypically-defined subpopulations; and mentoring junior investigators in how to conduct phase 2 and phase 3 NCTN trials, and in the administrative, scientific, and interpersonal skills needed for advancing into positions of leadership within the NCTN and National Cancer Institute.